DK0824517T3 - Fremgangsmåde til fremstilling af lercanidipinhydrochlorid - Google Patents
Fremgangsmåde til fremstilling af lercanidipinhydrochloridInfo
- Publication number
- DK0824517T3 DK0824517T3 DK96916111T DK96916111T DK0824517T3 DK 0824517 T3 DK0824517 T3 DK 0824517T3 DK 96916111 T DK96916111 T DK 96916111T DK 96916111 T DK96916111 T DK 96916111T DK 0824517 T3 DK0824517 T3 DK 0824517T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- lercanidipine hydrochloride
- lercanidipine
- hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI950957A IT1274480B (it) | 1995-05-12 | 1995-05-12 | Procedimento migliorato per la preparazione della lercanidipina cloridrato |
| PCT/EP1996/002122 WO1996035668A1 (en) | 1995-05-12 | 1996-05-09 | A process for the preparation of lercanidipine hydrochloride |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0824517T3 true DK0824517T3 (da) | 2002-11-18 |
Family
ID=11371581
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK96916111T DK0824517T3 (da) | 1995-05-12 | 1996-05-09 | Fremgangsmåde til fremstilling af lercanidipinhydrochlorid |
Country Status (37)
| Country | Link |
|---|---|
| EP (1) | EP0824517B1 (ja) |
| JP (1) | JP4038622B2 (ja) |
| KR (1) | KR100395441B1 (ja) |
| CN (1) | CN1101810C (ja) |
| AR (1) | AR002739A1 (ja) |
| AT (1) | ATE221050T1 (ja) |
| AU (1) | AU694046B2 (ja) |
| BG (1) | BG62400B1 (ja) |
| BR (1) | BR9608374A (ja) |
| CA (1) | CA2217849C (ja) |
| CZ (1) | CZ288634B6 (ja) |
| DE (1) | DE69622552T2 (ja) |
| DK (1) | DK0824517T3 (ja) |
| DZ (1) | DZ2032A1 (ja) |
| EA (1) | EA000346B1 (ja) |
| EE (1) | EE03351B1 (ja) |
| EG (1) | EG21755A (ja) |
| ES (1) | ES2179942T3 (ja) |
| HU (1) | HU226709B1 (ja) |
| IL (1) | IL118143A (ja) |
| IN (1) | IN188486B (ja) |
| IT (1) | IT1274480B (ja) |
| MA (1) | MA23858A1 (ja) |
| MX (1) | MX9708662A (ja) |
| MY (1) | MY113802A (ja) |
| NO (1) | NO309423B1 (ja) |
| NZ (1) | NZ309059A (ja) |
| PL (1) | PL185260B1 (ja) |
| PT (1) | PT824517E (ja) |
| RO (1) | RO119616B1 (ja) |
| SA (1) | SA96170216B1 (ja) |
| SK (1) | SK283321B6 (ja) |
| TN (1) | TNSN96069A1 (ja) |
| TW (1) | TW404940B (ja) |
| UA (1) | UA46769C2 (ja) |
| WO (1) | WO1996035668A1 (ja) |
| ZA (1) | ZA963716B (ja) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6852737B2 (en) | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
| ITMI20011726A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| JP2006504800A (ja) * | 2002-10-16 | 2006-02-09 | レコーダチ アイルランド リミテッド | リシノプリル／レルカニジピンの組み合わせ治療 |
| AR052918A1 (es) * | 2005-02-25 | 2007-04-11 | Recordati Ireland Ltd | Clorhidrato de lercanidipina amorfo |
| KR100713136B1 (ko) * | 2005-05-04 | 2007-05-02 | 주식회사 대희화학 | 무수 레르카니디핀 염화수소 결정다형의 개선된 신규결정화 방법 |
| ATE445602T1 (de) | 2005-06-15 | 2009-10-15 | Hetero Drugs Ltd | Neues verfahren zur herstellung von lercanidipin |
| WO2007031865A2 (en) | 2005-09-16 | 2007-03-22 | Glenmark Pharmaceuticals Limited | Polymorphic form of lercanidipine hydrochloride and process for the preparation thereof |
| KR100811497B1 (ko) * | 2005-10-19 | 2008-03-07 | 신풍제약주식회사 | 무수 염산 1,4-디하이드로피리딘 유도체의 제조 방법 |
| DE602006003877D1 (de) * | 2006-05-24 | 2009-01-08 | Cf Pharma Ltd | Verfahren zur Herstellung von Lercanipidin |
| KR100808281B1 (ko) * | 2006-06-30 | 2008-03-03 | 주식회사 하원정밀화학 | 레르카니디핀 및 그 산부가염의 제조방법 |
| CN102020602B (zh) * | 2009-09-18 | 2013-12-25 | 深圳信立泰药业股份有限公司 | 盐酸乐卡地平晶型及其制备方法和含有该晶型的药物组合物 |
| WO2011161223A2 (en) | 2010-06-23 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
| SI2654729T1 (sl) | 2010-12-24 | 2016-08-31 | Krka, D.D., Novo Mesto | Homogene farmacevtske oralne dozirne oblike, ki obsegajo lerkanidipin in enalapril ali njune farmacevtsko sprejemljive soli skupaj z organsko kislino |
| CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
| CN102516160B (zh) * | 2011-12-16 | 2014-04-02 | 华润赛科药业有限责任公司 | 一种高纯盐酸乐卡地平的合成工艺 |
| CN102584682A (zh) * | 2011-12-31 | 2012-07-18 | 苏州二叶制药有限公司 | 盐酸乐卡地平的制备方法 |
| CN109956943B (zh) * | 2019-04-18 | 2021-07-20 | 合肥合源药业有限公司 | 一种二氢吡啶类药物中脱羧缩合杂质及其制备、控制方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
-
1995
- 1995-05-12 IT ITMI950957A patent/IT1274480B/it active IP Right Grant
-
1996
- 1996-05-03 IL IL11814396A patent/IL118143A/en not_active IP Right Cessation
- 1996-05-06 IN IN822CA1996 patent/IN188486B/en unknown
- 1996-05-07 MA MA24223A patent/MA23858A1/fr unknown
- 1996-05-08 DZ DZ960075A patent/DZ2032A1/fr active
- 1996-05-09 MY MYPI96001751A patent/MY113802A/en unknown
- 1996-05-09 BR BR9608374A patent/BR9608374A/pt not_active Application Discontinuation
- 1996-05-09 PL PL96323236A patent/PL185260B1/pl unknown
- 1996-05-09 DE DE69622552T patent/DE69622552T2/de not_active Expired - Lifetime
- 1996-05-09 EE EE9700303A patent/EE03351B1/xx unknown
- 1996-05-09 DK DK96916111T patent/DK0824517T3/da active
- 1996-05-09 CA CA002217849A patent/CA2217849C/en not_active Expired - Lifetime
- 1996-05-09 EG EG40296A patent/EG21755A/xx active
- 1996-05-09 AT AT96916111T patent/ATE221050T1/de active
- 1996-05-09 ES ES96916111T patent/ES2179942T3/es not_active Expired - Lifetime
- 1996-05-09 HU HU9801913A patent/HU226709B1/hu unknown
- 1996-05-09 EP EP96916111A patent/EP0824517B1/en not_active Expired - Lifetime
- 1996-05-09 PT PT96916111T patent/PT824517E/pt unknown
- 1996-05-09 RO RO97-02101A patent/RO119616B1/ro unknown
- 1996-05-09 CN CN96193842A patent/CN1101810C/zh not_active Expired - Lifetime
- 1996-05-09 UA UA97125981A patent/UA46769C2/uk unknown
- 1996-05-09 SK SK1514-97A patent/SK283321B6/sk not_active IP Right Cessation
- 1996-05-09 EA EA199700374A patent/EA000346B1/ru not_active IP Right Cessation
- 1996-05-09 JP JP53379796A patent/JP4038622B2/ja not_active Expired - Lifetime
- 1996-05-09 CZ CZ19973567A patent/CZ288634B6/cs not_active IP Right Cessation
- 1996-05-09 WO PCT/EP1996/002122 patent/WO1996035668A1/en active IP Right Grant
- 1996-05-09 AU AU58985/96A patent/AU694046B2/en not_active Expired
- 1996-05-09 NZ NZ309059A patent/NZ309059A/xx not_active IP Right Cessation
- 1996-05-09 KR KR1019970707905A patent/KR100395441B1/ko not_active IP Right Cessation
- 1996-05-10 AR ARP960102528A patent/AR002739A1/es unknown
- 1996-05-10 TN TNTNSN96069A patent/TNSN96069A1/fr unknown
- 1996-05-10 TW TW085105567A patent/TW404940B/zh not_active IP Right Cessation
- 1996-05-10 ZA ZA963716A patent/ZA963716B/xx unknown
- 1996-08-07 SA SA96170216A patent/SA96170216B1/ar unknown
-
1997
- 1997-11-07 BG BG102034A patent/BG62400B1/bg unknown
- 1997-11-11 MX MX9708662A patent/MX9708662A/es unknown
- 1997-11-11 NO NO975176A patent/NO309423B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0770615T3 (da) | Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner | |
| DK0747116T3 (da) | Fremgangsmåde til fremstilling af mikrokapselsammensætninger | |
| DK0754756T3 (da) | Fremgangsmåde til fremstilling af L-lysin | |
| DK0775100T3 (da) | Fremgangsmåde til fremstilling af trifluorethylen | |
| DK0797542T3 (da) | Fremgangsmåde til fremstilling af aluminosilikatderivater | |
| DK1005517T3 (da) | Fremgangsmåde til fremstilling af diglycerider | |
| DK0719788T3 (da) | Fremgangsmåde til fremstilling af 1-(2'-deoxy-2',2'-difluor-D-ribofuranosyl)-4-aminopyrimidin-2-on-hydrochlorid | |
| DK0824517T3 (da) | Fremgangsmåde til fremstilling af lercanidipinhydrochlorid | |
| DK0839138T3 (da) | Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler | |
| DK0768310T3 (da) | Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater | |
| NO974169D0 (no) | Fremgangsmåte for tetra-azacykloalkan-fremstilling | |
| DK0805797T3 (da) | Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer | |
| DK0756597T3 (da) | Fremgangsmåde til fremstilling af puriner | |
| DK0877738T3 (da) | Fremgangsmåde til fremstilling af phenylimidazolidinderivater | |
| DK1027315T3 (da) | Fremgangsmåde til fremstilling af n-butanol | |
| DK0873326T3 (da) | Fremgangsmåde til fremstilling af 2-chlorthiazolforbindelser | |
| DK1028960T3 (da) | Fremgangsmåde til fremstilling af thiazolidinedion | |
| DK0946514T3 (da) | Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler | |
| DK0864564T3 (da) | Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater | |
| DK0815092T3 (da) | Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner | |
| DK0648738T3 (da) | Fremgangsmåde til fremstilling af acetoacetarylamider | |
| DK0871616T3 (da) | Fremgangsmåde til fremstilling af lægemidler mod malaria | |
| DK0648748T3 (da) | Fremgangsmåde til fremstilling af 5-acetoacetylaminobenzimidazolon-2 | |
| DK0721929T3 (da) | Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner | |
| DK1012152T3 (da) | Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer |